Trial Profile
A dose-finding study of efficacy and safety of F13640 in patients with moderate to severe painful peripheral diabetic polyneuropathy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Oct 2019
Price :
$35
*
At a glance
- Drugs Befiradol (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- Acronyms BEST
- 24 Oct 2019 Status changed from recruiting to completed.
- 14 Jun 2011 New trial record